Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Urinary Tract Infection

  Free Subscription


16.11.2026

1 ACS Infect Dis
1 ACS Omega
1 Acta Neurochir (Wien)
1 Biomed Pharmacother
1 BMC Infect Dis
1 BMJ Open
1 Br J Nurs
1 Braz J Microbiol
1 Child Kidney Dis
1 Clin Microbiol Infect
2 Diagn Microbiol Infect Dis
1 Disabil Health J
1 Discov Nano
2 Front Pharmacol
1 Infect Dis Now
1 Infect Prev Pract
1 J Am Pharm Assoc (2003)
1 J Endourol
1 J Paediatr Child Health
1 J Vet Intern Med
1 JBJS Rev
1 Low Urin Tract Symptoms
1 Nat Commun
2 Pediatr Infect Dis J
1 Pediatr Int
1 Pediatr Nephrol
1 PLoS One
1 Transl Androl Urol
1 West J Emerg Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Infect Dis

  1. MITRA M, Chen Z
    Targeting Force-Regulated FimH Adhesin: Assays, Mannosides, and Biologics for Anti-Virulence Therapy of UPEC Infection.
    ACS Infect Dis. 2026;12:3596-3611.
    PubMed         Abstract available


    ACS Omega

  2. STADLER E, Sutton M, Brown C, de Boer W, et al
    Rapid Point-of-Care Quantification of Urinary Tract Infection Biomarker Xanthine Oxidase.
    ACS Omega. 2026;11:69381-69388.
    PubMed         Abstract available


    Acta Neurochir (Wien)

  3. THEOFANOPOULOS A, Assimakopoulos SF, Faropoulos K, Constantoyannis C, et al
    Predictors of postoperative infections in a tertiary neurosurgical center.
    Acta Neurochir (Wien). 2026;168:258.
    PubMed         Abstract available


    Biomed Pharmacother

  4. GRAZIOSI A, Riemma MA, Gurgone D, Schianchi A, et al
    Urinary tract and genital infections with dapagliflozin and empagliflozin across type 2 diabetes, heart failure, and chronic kidney disease: An indication- and sex-stratified disproportionality analysis of eudravigilance reports.
    Biomed Pharmacother. 2026;204:119976.
    PubMed         Abstract available


    BMC Infect Dis

  5. CHOTALIYA GV, Mehta KD, Shrivastav VN, Karangia M, et al
    Prevalence of ESBL-producing Escherichia coli in urinary tract infections and their in-vitro susceptibility to Fosfomycin: a tertiary care experience.
    BMC Infect Dis. 2026;26:1990.
    PubMed         Abstract available


    BMJ Open

  6. IBRAHIM LF, Orsini F, Kochar A, Craig S, et al
    CHOICE-UTI: protocol for a multicentre randomised non-inferiority trial comparing single versus three daily doses of intravenous antibiotics prior to oral therapy for complicated urinary tract infection in children.
    BMJ Open. 2026;16:e119766.
    PubMed         Abstract available


    Br J Nurs

  7. HOWCROFT E
    Developing a digital knowledge-to-practice framework for urinary device management and CAUTI surveillance.
    Br J Nurs. 2026;35:996-1002.
    PubMed         Abstract available


    Braz J Microbiol

  8. HUAYCHO-GUZMAN EJ, Quispe-Misme JR, Quispe-Jurado X, Marin Carrasco M, et al
    Correction to: Detection of high-risk sequence type ST131 among multidrug-resistant Escherichia coli causing urinary tract infections in Cusco, Peru.
    Braz J Microbiol. 2026;57:323.
    PubMed        


    Child Kidney Dis

  9. LEE JW
    From surveillance to stewardship: responding to changing resistance in pediatric urinary tract infections.
    Child Kidney Dis. 2026;30:161-163.
    PubMed        


    Clin Microbiol Infect

  10. BIHAM O, Burrack N, Hassan L, Nesher L, et al
    Sodium-glucose co-transporter 2 inhibitors and risk of bacteriuria, candiduria, and urinary tract infection-related hospitalization: a nationwide cohort study.
    Clin Microbiol Infect. 2026 Oct 27:S1198-743X(26)00599.
    PubMed         Abstract available


    Diagn Microbiol Infect Dis

  11. UWAMINO Y, Yamada T, Yamamoto G, Aoki W, et al
    Performance evaluation of an end-to-end fully automated AI-assisted gram staining system using clinical urine specimens: A multicenter prospective study.
    Diagn Microbiol Infect Dis. 2027;117:117665.
    PubMed         Abstract available

  12. HUANG T, Mao H, Jiang X, Hu M, et al
    Application and effect of a data-driven multidimensional intervention model in reducing urine culture contamination rates.
    Diagn Microbiol Infect Dis. 2027;117:117673.
    PubMed         Abstract available


    Disabil Health J

  13. CALDERONE A, Raciti L, Onesta MP, Piccione M, et al
    Women vs men after traumatic spinal cord injury: Longitudinal sex differences in secondary complications, rehospitalization burden, and community participation.
    Disabil Health J. 2027;20:102138.
    PubMed         Abstract available


    Discov Nano

  14. SADDAM M, Mishra SK, Kumar V, Singh N, et al
    Exploring the potential of herbal nanotechnology for the treatment of urinary tract infections.
    Discov Nano. 2026;21:632.
    PubMed         Abstract available


    Front Pharmacol

  15. ZHANG P, Zhang X, Ji C, Hu W, et al
    Chinese herbal medicine for recurrent urinary tract infection: formulation-specific clinical evidence, experimental pharmacology, and unresolved recurrence mechanisms.
    Front Pharmacol. 2026;17:1950004.
    PubMed         Abstract available

  16. TANG Y, Cai Y, Zhou Y, Ji R, et al
    Clinical research landscape and evidence gaps in Traditional Chinese Medicine for recurrent urinary tract infections: a scoping review.
    Front Pharmacol. 2026;17:1906640.
    PubMed         Abstract available


    Infect Dis Now

  17. LAI SW, Liao KF
    Short-term risk of herpes zoster following acute pyelonephritis vs. lower urinary tract infection: a propensity score-matched cohort study: Short title: Acute pyelonephritis and herpes zoster.
    Infect Dis Now. 2026 Nov 10:105394. doi: 10.1016/j.idnow.2026.105394.
    PubMed         Abstract available


    Infect Prev Pract

  18. AL-ZUBEIDI D, Hogan PG, Choi S, Massinello B, et al
    Urinary tract infections in children with medical complexity at paediatric postacute care facilities: variability in diagnosis and treatment.
    Infect Prev Pract. 2026;8:100611.
    PubMed         Abstract available


    J Am Pharm Assoc (2003)

  19. LE T, Kelly T
    Pharmacist test-and-treat authority and empirical antibiotic prescribing: Evidence from state Medicaid data.
    J Am Pharm Assoc (2003). 2026;66:103512.
    PubMed         Abstract available


    J Endourol

  20. SIRON N, Hafeez Z, Samala V, Dalton D, et al
    Characterizing Neurogenic Bladder Patients Undergoing Percutaneous Nephrolithotomy: Examining Concordance of Preoperative Urine and Stone Cultures.
    J Endourol. 2026;40:1336-1339.
    PubMed         Abstract available


    J Paediatr Child Health

  21. SMITH GHH
    Urinary Tract Infections, Known Unknowns and Groupthink.
    J Paediatr Child Health. 2026 Nov 10. doi: 10.1111/jpc.70640.
    PubMed         Abstract available


    J Vet Intern Med

  22. POHLMANN M, LeCuyer TE, Woerde D, Palm C, et al
    In vitro susceptibility of antimicrobial resistant strains of Escherichia coli isolated from the urine of dogs to pivmecillinam and fosfomycin.
    J Vet Intern Med. 2026;40:aalag266.
    PubMed         Abstract available


    JBJS Rev

  23. LAZKANI A, Batrash F, Jasti S, Mahmoud T, et al
    Urinary Tract Infection, Asymptomatic Bacteriuria, and Perioperative Decision-Making in Spine Surgery.
    JBJS Rev. 2026;14.
    PubMed         Abstract available


    Low Urin Tract Symptoms

  24. FENG D, Parkin CJ, Moritz P, Chung A, et al
    Determinants of UTI-Related Hospital Admissions in Spinal Cord Injury Patients: The Impact of Injury Characteristics and Bladder Management.
    Low Urin Tract Symptoms. 2026;18:e70103.
    PubMed         Abstract available


    Nat Commun

  25. CHAZIN-GRAY AM, Thompson TR, Lopatto EDB, Magala P, et al
    De novo design of miniprotein inhibitors of bacterial adhesins.
    Nat Commun. 2026;17:11554.
    PubMed         Abstract available


    Pediatr Infect Dis J

  26. SANCHEZ-ARRANZ E, Arellano Subias M, Garcia-Ascaso MT, Bassy Navarro S, et al
    Antimicrobial-resistant Urinary Tract Infections in Febrile Infants: Prevalence, Associated Factors and Clinical Outcomes.
    Pediatr Infect Dis J. 2026 Nov 5. doi: 10.1097/INF.0000000000005463.
    PubMed         Abstract available

  27. BRADLEY JS, Norice CT, Roilides E, Shevelev A, et al
    Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.
    Pediatr Infect Dis J. 2026 Jul 7. doi: 10.1097/INF.0000000000005323.
    PubMed         Abstract available


    Pediatr Int

  28. ISBIR C, Elhakan F, Colak S, Tasan L, et al
    The Role of Ureteral Stent Intravesical Position in Postoperative Urinary Tract Infection in Children With Urolithiasis.
    Pediatr Int. 2026;68:e70586.
    PubMed         Abstract available


    Pediatr Nephrol

  29. YILDIRIM ZNY, Afonso AC, Akil I, Aksu B, et al
    The role of antimicrobial polypeptides in predicting urinary tract infection: UTILISE study.
    Pediatr Nephrol. 2026 Nov 10. doi: 10.1007/s00467-026-07578.
    PubMed         Abstract available


    PLoS One

  30. PLATE A, Heinz N, Thiruchelvam T, Meyer-Massetti C, et al
    General practitioners' perspectives on treatment decisions and interprofessional care for women with uncomplicated urinary tract infections: An exploratory qualitative study.
    PLoS One. 2026;21:e0362328.
    PubMed         Abstract available


    Transl Androl Urol

  31. PROKESCH BC, Zimmern PE
    The SCOUT agree: nitrofurantoin is safe and effective for first-line treatment of uncomplicated lower urinary tract infections in women.
    Transl Androl Urol. 2026;15:393.
    PubMed        


    West J Emerg Med

  32. NASTA C, Onorato L, Allegorico E, Palumbo F, et al
    Sex Differences in Outcome and Mortality in Urinary Tract Infections in the Emergency Department: The UTILY Study.
    West J Emerg Med. 2026;27:1623-1630.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Urinary Tract Infection is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum